Table 3.

Within-Treatment Cocaine Outcomes (Months 1 to 6) Predicting 12 Month (after baseline) Follow-Up Functioning

	ASI Scales at 12 Months
Within-Treatment Outcome	Psych	Family/Social	Medical	Legal	Employment
Average times used cocaine past week	.13*	.09	−.05	.15**	.14*
Max. consecutive days abstinent from cocaine from self-report	−.00	−.11	.04	−.10	−.05
Completely abstinent (urine + self-report)	−.02	−.10	.07	−.08	−.03
4+ weeks of abstinence (urine + self-report)	.02	−.05	−.05	−.14*	.09
3+ weeks of abstinence (urine + self-report)	−.03	−.03	−.09	−.16**	−.10
2+ weeks of abstinence (urine + self-report)	.02	−.06	.10	−.17**	−.03
1+ weeks of abstinence (urine + self-report)	−.02	−.07	−.04	−.15**	−.05
Percent reduction in cocaine use from baseline to month 6 (self-report)	−.13*	−.07	−.01	−.14*	−.14*
50% reduction from baseline (yes/no)	−.16**	−.10	.00	−.17**	−.06
% (of available) Negative Urines for cocaine	−.04	−.06	−.01	−.12*	.07
% (scheduled) Negative Urines for cocaine	−.02	−.09	.04	−.15*	−.03
McCann and Li End-of-Study Measures
EOSA – 1+ wks	−.00	−.04	.09	.02	.07
EOSA -2+ wks	−.03	−.12	.08	−.05	−.01
EOSA -3+ wks	−.07	−.08	.02	−.04	−.12*
EOSA – 4+ wks	−.13*	−.06	.01	−.01	−.09
NOBWOS – 1+ wks	−.06	−.07	.03	−.02	−.08
NOBWOS – 2+ wks	−.06	−.06	.02	−.01	−.08
NOBWOS – 3+ wks	−.05	−.05	.02	−.01	−.07
NOBWOS – 4+ wks	−.04	−.05	.03	−.01	−.07
Number of consec. wks abstinent from endpoint	−.05	−.07	.04	−.01	−.06

Note. Partial correlations shown with treatment group, site, and baseline ASI scores as covariate. N's vary from 337 to 363. EOSA = end of study abstinence. NOBWOS = number of beyond-threshold weeks of success. Lower ASI scores = fewer problems.

^*p < .05.

^**p < .01